Delivery Order SPE2DB22D3016-SPE2DB25FBGS3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets on August 5, 2025, with a ceiling value of $9,438.70. This firm fixed price delivery order, which is not set aside for any specific business category, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. PREVYMIS (letermovir) is an antiviral medication primarily used for cytomegalovirus prophylaxis in...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets (7-count units) with a completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. PREVYMIS (letermovir) is an antiviral medication used primarily for cytomegalovirus prophylaxis in immunocompromised...
- The Defense Logistics Agency Troop Support Medical awarded a $4,287 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 480 mg tablets of PREVYMIS. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide 7 tablets of PREVYMIS, to be delivered to its facility in Conshohocken, Pennsylvania by August 30, 2023. No subcontractors or set-aside designations were identified. PREVYMIS is an...
- The U.S. Defense Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets in quantities of seven tablets, valued at $4,719.34. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive award under the company's existing contract vehicle. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. Prevymis...
- The Defense Logistics Agency awarded a $4.7K delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for PREVYMIS 480 mg tablets (7-count packaging). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 MG tablets in a quantity of 7 units, valued at $9,438.70. This is a firm fixed price delivery order issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, and the place of performance...
- The Defense Logistics Agency awarded a $8,574.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 480 mg tablets of Prevymis. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of seven boxes of the antiviral drug to a facility in Conshohocken, Pennsylvania by August 24, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this order placed by the DLA, which manages the...
- The Defense Logistics Agency awarded a $8,597.04 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561470788 PREVYMIS 240 MG TABLET 7S. This order is being issued against an existing Prime Vendor contract vehicle to supply the antiviral medication PREVYMIS in tablet form to locations within Conshohocken, Pennsylvania, with performance required between July 10-31, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to...
- The Defense Logistics Agency Troop Support Medical awarded a $4,287 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 480 mg tablets of PREVYMIS. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Amerisourcebergen will deliver the PREVYMIS tablets to its facility located in Conshohocken, Pennsylvania by August 22, 2023, fulfilling the...
- This delivery order for $4,287.02, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for 780 tablets of Prevymis 480 mg to be delivered by November 6, 2023. Prevymis is an antiviral medication used to prevent cytomegalovirus infection and disease in at-risk patients. The contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania. No set-aside designation was used for this award made under an existing indefinite-delivery/indefinite-quantity...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGS3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,316.04 to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 mg tablets (quantity 7s) to be performed in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a non-competitive, non-set-aside procurement. PREVYMIS (letermovir) is an antiviral medication used primarily for cytomegalovirus prophylaxis in immunocompromised populations, particularly relevant for military and veteran healthcare systems supported by the Defense Health Agency. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with extensive experience fulfilling military healthcare pharmaceutical needs across multiple therapeutic domains. The company's status as a child contract under this prime IDV demonstrates its established capability to meet federal pharmaceutical supply requirements through the DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.3k | 8/29/25 |